Article Details

On March, 14 Analysts See $-0.82 EPS for Coherus BioSciences, Inc. (CHRS)

Retrieved on: 2019-03-02 00:08:30

Tags for this article:

Click the tags to see associated articles and topics

On March, 14 Analysts See $-0.82 EPS for Coherus BioSciences, Inc. (CHRS). View article details on hiswai:

Excerpt

<div><b>Kohlberg Kravis Roberts</b> & Lp owns 3.06M shs or 0.57% of their US capital. New York-based Tiaa Cref Mngmt Ltd Liability Com has invested 0.01% in ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up